Juan Jesús
Cruz Hernández
Profesor Emérito
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (12)
2023
-
Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 4
2020
-
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
Scientific Reports, Vol. 10, Núm. 1
2019
-
Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population
Cancers, Vol. 11, Núm. 4
-
Working towards a consensus on the oncological approach of breakthrough pain: A Delphi survey of Spanish experts
Journal of Pain Research, Vol. 12, pp. 2349-2358
2017
-
Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma
Scientific Reports, Vol. 7, Núm. 1
-
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study
International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 3, pp. 473-480
-
GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)
British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774
-
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: A multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
Annals of Oncology, Vol. 28, Núm. 12, pp. 2994-2999
-
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics
Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34
2016
-
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos
Revista de Psiquiatria y Salud Mental
-
Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1114-1122
-
Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study
Oral Oncology, Vol. 62, pp. 54-59